Red Queen Therapeutics

Red Queen Therapeutics is a clinical-stage company based in the United States, working to develop innovative antiviral therapies that block virus-cell fusion and halt disease progression. Their novel stapled lipopeptide platform technology offers key advantages, including a high barrier to resistance, room temperature stability, and versatile formulations for easy administration.